Get more information on Medical Nonwoven Disposable Market - Request Sample Report
The Medical Nonwoven Disposable Market Size was valued at USD 22.31 billion in 2023 and is expected to reach USD 68.09 billion by 2032 and grow at a CAGR of 13.22% over the forecast period 2024-2032.
The rising number of accidents and trauma cases, as well as the rising number of urgent illnesses requiring immediate surgical treatment, are only a few of the drivers driving the medical nonwoven disposables market forward. This is mostly owing to nonwoven disposable products' advantages over woven textile products, such as the absence of cross-contamination and excellent bacterial filtration effectiveness. The rising popularity of robot-assisted and non-invasive operations, as well as environmental concerns about their disposal, are limiting factors in this industry. Market penetration of medical nonwoven disposables will be aided by technological advancements in the manufacturing of biodegradable disposable products and an increase in the number of hospitals and clinics performing surgical operations.
Incontinence products and medical nonwoven products are among the products under consideration. Medical nonwoven products include surgical drapes, surgical shoe covers, surgical caps, surgical gowns, sterile nonwoven swabs, and others. Incontinence products include disposable underwear, cotton pads, panty shields, and disposable diapers (ultra sorbent disposable diapers, superabsorbent disposable diapers, and biodegradable disposable diapers). Estimates of market size and forecasts for these categories over the next few years.
DRIVERS
Infections acquired in hospitals are becoming more common
Increase in demand
Government increased the awareness
RESTRAINTS/ CHALLENGES
Degradation of the environment
The growing popularity of minimally invasive operations
lack of awareness
OPPORTUNITIES
Increase in nanotechnology
Increase in R&D activities
Rise in the number of emerging market
The new COVID-19 flare-up has started a flood sought after for nonwoven-based facemasks. The medical nonwoven disposables industry is still being driven by the fear of infectious diseases like SARS and H1N1. Nonwovens help keep costs down, therefore fighting infection has become one of the top priorities for healthcare providers. Furthermore, WHO guidelines produced under the Infection Prevention and Control (IPC) program are raising user awareness of the importance of personal cleanliness. This is clear because the revenue of the medical nonwoven disposables market's consumer & home healthcare end-user segment is expected to rise tremendously over the forecast period.
Based on product Incontinence products and sterile nonwoven products make up the medical nonwoven disposables industry. Disposable underwear, cotton pads, disposable diapers, and feminine hygiene products are several types of incontinence goods. Disposable surgical masks, respirators, surgical gowns, drapes, and other sterile nonwoven items were also created. The most profitable segment is sterile nonwoven products, followed by incontinence hygiene items. The market is expected to rise due to factors such as an increase in the elderly population, high disposable income, and an increase in hospital demand for nonwoven disposables. Furthermore, due to significant advancements in nonwoven production technology and an increased focus on reducing hospital acquired infections, the incontinence products category is the leading contributor to market growth.
By Product Type
Disposable Surgical Masks
Disposable Surgical Caps
Disposable Diapers
Disposable Underwear
Disposable Surgical Gowns
Other
North America had the largest share of the worldwide medical nonwoven disposables market, led by other sectors. The increased importance of the North American region can be ascribed to improvements in healthcare infrastructure and services in emerging countries, as well as increases in disposable money and public health awareness. In the future years, the demand for nonwoven disposables in both developing as well as developed parts of North America is expected to skyrocket.
Need any customization research on Medical Nonwoven Disposable Market - Enquiry Now
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
The key players are Asahi Kasei Corporation, Berry Global Incorporated, Ahlstrom-Munksj, Cardinal Health Inc., First Quality Enterprises Inc., Domtar Corporation, Freudenberg & Co. KG., Kimberly Clark Corporation, Unicharm Corporation, Georgia-Pacific LLC, and Other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 22.31 Billion |
| Market Size by 2032 | USD 68.09 Billion |
| CAGR | CAGR of 13.22% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Disposable Surgical Masks, Disposable Surgical Caps, Disposable Diapers, Disposable Underwear, Disposable Surgical Gowns, Other) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Asahi Kasei Corporation, Berry Global Incorporated, Ahlstrom-Munksj, Cardinal Health Inc., First Quality Enterprises Inc., Domtar Corporation, Freudenberg & Co. KG., Kimberly Clark Corporation, Unicharm Corporation, Georgia-Pacific LLC |
| Drivers | • Infections acquired in hospitals are becoming more common • Increase in demand • Government increased the awareness |
| Restraints | • Degradation of the environment • The growing popularity of minimally invasive operations • Lack of awareness |
Ans:- The Medical Nonwoven Disposable market size was valued at USD 22.31 billion in 2023.
Infections acquired in hospitals are becoming more common, increases in demand, are all propelling the Medical Nonwoven Disposable market forward.
North America had the largest share of the worldwide medical nonwoven disposables market, led by other sectors.
Asahi Kasei Corporation, Berry Global Incorporated, Ahlstrom-Munksj, Cardinal Health, Inc., First Quality Enterprises, Inc., and Domtar Corporation are the key players in the Medical Nonwoven Disposable Market.
Ans:- The Medical Nonwoven Disposable Market is growing at a CAGR of 13.22% over the forecast period 2024-2032.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Medical Nonwoven Disposable Market Segmentation, by Product Type
8.1 Disposable Surgical Masks
8.2 Disposable Surgical Caps
8.3 Disposable Diapers
8.4 Disposable Underwear
8.5 Disposable Surgical Gowns
8.6 Other
9. Regional Analysis
9.1 Introduction
9.2 North America
9.2.1 USA
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 The Netherlands
9.3.7 Rest of Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 South Korea
9.4.3 China
9.4.4 India
9.4.5 Australia
9.4.6 Rest of Asia-Pacific
9.5 The Middle East & Africa
9.5.1 Israel
9.5.2 UAE
9.5.3 South Africa
9.5.4 Rest
9.6 Latin America
9.6.1 Brazil
9.6.2 Argentina
9.6.3 Rest of Latin America
10. Company Profiles
10.1 Asahi Kasei Corporation
10.1.1 Financial
10.1.2 Products/ Services Offered
10.1.3 SWOT Analysis
10.1.4 The SNS view
10.2 Berry Global Incorporated
10.3 Ahlstrom-Munksj
10.4 Cardinal Health, Inc.
10.5 First Quality Enterprises, Inc.
10.6 Domtar Corporation
10.7 Freudenberg & Co. KG.
10.8 Kimberly Clark Corporation
10.9 Unicharm Corporation
10.10 Georgia-Pacific LLC.
11. Competitive Landscape
11.1 Competitive Benchmark
11.2 Market Share Analysis
11.3 Recent Developments
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Flow Cytometry Market Size was valued at USD 4.91 billion in 2023 and is anticipated to reach over USD 8.96 billion by 2031 with an emerging CAGR of 7.80% Over the Forecast Period of 2024-2031.
The Venous Leg Ulcer (VLU) Treatment Market Size was valued at USD 4.07 billion in 2023, and is expected to reach USD 7.3 billion by 2032, and grow at a CAGR of 6.7% over the forecast period 2024-2032.
The Muscle Stimulator Market size was valued at USD 783.8 million in 2023 and is expected to reach USD 1077.56 million by 2032 and grow at a CAGR of 3.6% over the forecast period 2024-2032.
The Virtual Clinical Trials Market Size is projected to reach USD 14.89 billion by 2032 growing at a CAGR of 6.07% for the forecast period 2024 to 2032
The Demineralized Bone Matrix (DBM) Market Size was valued at USD 1.29 billion in 2023 and is projected to reach USD 2.18 billion by 2032 with a growing CAGR of 5.98% Over the Forecast Period of 2024-2032.
The Medication Management Market Size was valued at USD 7.08 Billion in 2023 and is expected to reach USD 13.37 Billion by 2032 and grow at a CAGR of 7.66% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
